Secure an appointment with our trusted travelling surgeon today. Your Pet Deserves the Best – Book Now!

OUR SERVICES

Cranial Cruciate Ligament Disease

ABOUT CRANIAL CRUCIATE LIGAMENT DISEASE

At VetLove Advanced Surgery, we understand the distress and pain that cranial cruciate ligament deficiency (CCLD) can cause for both you and your pet.

Cranial cruciate ligament deficiency (CCLD)
The cranial cruciate ligament (CCL), equivalent to the anterior cruciate ligament, or ACL in people, is responsible for limiting hyperextension of the stifle, limiting internal rotation of the tibia in relation to the femur, and to prevent forward sliding/drawer motion of the tibia in relation to the femur. Cranial cruciate ligament deficiency (CCLD) is the most common cause of hind limb lameness in dogs. Deficiency in the ligament is frequently progressive, starting with the initial trauma and progressing through partial rupture to complete rupture, is the most common cause of hind limb lameness in dogs.

The underlying cause of CCLD in the majority of dogs is different than ACL injuries in most people. While trauma is a common cause of ACL tears in people and dogs do suffer from traumatic ruptures, CCLD in dogs is typically degenerative in nature. Some proposed predisposing factors for cruciate injuries in dogs include genetics, obesity and poor fitness level, early neutering, excessive tibial plateau angle (TPA), immune-mediated disease, neoplasia (cancer), and bacterial presence within the joint. Young to middle-aged, female, large breed dogs are at greatest risk for tearing their CCL, though any dog can develop CCLD.

Though the underlying cause of the disease may be different in each dog, the anatomy of the joint and the forces applied through it during weight bearing movement play a role in the continued breakdown of the ligament.

The dog stifle (knee) is anatomically very similar to a human knee. There are two long bones, the femur (thigh bone) and the tibia (shin bone), and a small bone, the patella (knee cap), which articulate together. There are also four ligaments primarily responsible for the stability of the stifle – the cranial cruciate, caudal cruciate, medial collateral, and lateral collateral. Finally, there are two menisci, medial and lateral, which help act as a cushion between the femur and the tibia and help to provide congruency and further stability to the joint. An important difference between a dog stifle and the human knee is that the top of a dog tibia, the tibial plateau, has a more significant slope than that of a human knee.

Due to the slope of the top of the tibia (referred to as the tibial plateau angle), the cranial cruciate ligament of the dog is under stress during weight bearing as it attempts to keep the femur and the tibia in appropriate alignment. Once the integrity of the ligament is compromised, the tibia begins to move forward in relation to the femur during weight bearing, this is referred to as tibial thrust. This instability causes discomfort, frequently damages the medial meniscal ligament, and prevents normal ambulation. There is some evidence that the steeper the tibial plateau slope, the greater the likelihood of a dog developing a CCLD. As the cruciate ligament tears, changes are also taking place in the joint leading to a loss of healthy cartilage early on and a complete loss of cartilage in end-stage arthritis. In most patients, once the degenerative process of the CCL begins, the ligament will progress to a complete tear over time.

Clinical signs of early (partial) CCLD may include an acute onset of hind limb lameness following activity (can be weight bearing or non-weight bearing) that improves with time and is followed by intermittent stiffness after rising or mild to moderate lameness following heavy activity. As the disease advances and the ligament progressively tears, the lameness may become more consistent. Acute complete tears may initially result in a non-weight bearing lameness on the limb, but as time goes on the dog may intermittently use the limb. Instability in the joint associated with CCLD can also lead to injury of the meniscus. Injury of the meniscus can be extremely painful for pets and may, for a period of time, lead to a non-weight bearing lameness.

There are multiple tests veterinarians can perform to help diagnose a cranial cruciate ligament deficiency. One of the first signs present prior to instability may be pain with full extension (hyperextension) of the knee. This pain is likely due to stretching of the intact or strained fibres of the cruciate ligament. Once the ligament tears to a certain degree the tibia can be manually manipulated to show instability in what is called the “cranial drawer test” in which the tibia can be moved forward in relation to the femur. Another sign referred to as tibial thrust, may be elicited as well. With this test, weight bearing is mimicked, and the front of the tibia can be noted to be pushing forward in relation to the femur. It is important to keep in mind that many patients with clinical signs of pain and lameness may have a partial tear of the CCL. In these cases, there may not be any obvious instability (cranial drawer or tibial thrust) on the exam, however, the patient has a torn CCL that will likely progress to a complete tear.

Other signs that may be noted on the physical exam include loss of muscle mass (atrophy), detection of effusion (swelling) within the joint, and scar tissue formation around the knee (buttress). This scar tissue is the body’s natural response to try and stabilize an unstable joint. Long-term this scar tissue leads to a decreased range of motion in the knee. Finally, a “clicking” sound may be noted in a small percentage of patients with meniscal tears.

Though the cranial cruciate ligament is not visible on an x-ray, radiographs can help confirm a diagnosis of a CCLD by detection of changes that occur in the joint following CCL injury. These changes include effusion (excess fluid in the stifle), arthritis, and forward movement of the tibia relative to the femur. Radiographs are also used to rule out other concurrent injuries that may affect treatment options and recovery from CCLD.

Treatment Options:
Surgical treatment options are always performed in combination with non-surgical management and consistently outperform non-surgical management when performed alone for all dogs, offering the most predictable long-term outcome. Non-surgical management is always included in any treatment plan because osteoarthritis will develop due to the rupture regardless of the treatments, and targeted management is vital to reducing the rate of its progression.

The choice to pursue surgical treatment in addition to non-surgical management is influenced by factors such as your dog’s size, the stage of the disease, the amount of instability present, the expectations you have for your pet’s activity level/quality of life, and the presence of any other concurrent medical conditions (such as other orthopedic disease, severe heart disease, uncontrolled hormonal disease, cancer, etc.). Surgical intervention is almost always recommended to maximize the outcome and recovery of your pet.

Non-surgical management focuses on weight management, exercise modification, joint supplements/adjunctive therapies, and pain management with anti-inflammatories and/or pain medications. Historical literature states that about 80% of dogs under 15 kg may see an improvement in their comfort and mobility with successful non-surgical management; however, the improvement is rarely to the level that surgical intervention can achieve. In contrast to smaller breeds, non-surgical management in larger breeds has typically been overwhelmingly unsuccessful in returning dogs to full function. If proceeding with non-surgical management, it is important to acknowledge that the expectations are for your pet to be able to move around the house, but high-energy movement (running, jumping, long walks, playing, etc.) will likely be followed by a period of discomfort.

Weight management:
Obesity has been found to quadruple the risk of CCLD, and weight loss is likely the most important factor in medically managing a pet suffering from CCLD.

Obese dogs experience an earlier onset and faster progression of osteoarthritis. Reducing a pet’s weight and keeping them lean decreases the forces applied to joints, decreases systemic inflammation, and reduces muscle fatigue. In dogs that have already torn one CCL, weight loss may be crucial in preventing or delaying a rupture of the opposite limb, with literature noting that 80% of dogs will rupture the CCL in the other limb within 24 months of the first rupture.

Exercise modification:
Regular controlled physical activity, or rehabilitation, is crucial in treating osteoarthritis in animals. These activities may include stretching and range of motion exercises, controlled walking, and swimming. Advanced techniques, such as those used by physical rehabilitation specialists (balance boards, underwater treadmills, etc.), can also be utilized. The efficacy of physical rehabilitation in dogs with osteoarthritis has been proven in multiple scientific studies.

Consistent, tolerable levels of activity are most beneficial. In addition to the contribution physical activity can have on weight management, it helps maintain joint range of motion, muscle mass, and comfort. If a pet can gradually increase their stamina by extending the duration of their activity, this is ideal. Multiple short walks are better than one long walk. If high-impact activities such as fetch or playing with other pets are expected, a ‘warm-up’ period of walking may decrease the risk of injury. Avoiding excessive high-impact activity in pets with osteoarthritis is important, as is avoiding exercises that cause post-exercise discomfort.

Joint supplements/adjunctive therapies:
Unfortunately, there is very little evidence in the veterinary literature to support the broad use of joint supplements. While there are positive reports for supplements and anti-arthritic injections, an individually tailored approach is vital to maximize potential benefits.

Fish-derived Omega-3 fatty acids contain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). A few studies have noted improvements in clinical outcome measures, including mobility, reduced non-steroidal anti-inflammatory drug use, discomfort, lameness, and severity of joint disease.

Polysulfated glycosaminoglycan (Adequan) is an injectable drug that aims to support joint (articular) cartilage, inhibit catabolic enzymes that degrade cartilage, and inhibit the production of chemical factors that can lead to inflammation and pain. Adequan is usually administered as a series of 8 injections over 4 weeks.

Another medication used to treat joint disease in dogs is Synovan. It contains two active ingredients that work together to stimulate cartilage repair, reduce joint inflammation, and alleviate pain. The medication is usually administered as a series of 4 injections over 4 weeks.

Monoclonal antibody therapy (Beransa) is designed to manage chronic pain associated with osteoarthritis by neutralizing a protein involved in pain signaling. This helps improve mobility and quality of life for animals with osteoarthritis. The injection is typically given on a monthly schedule. Unlike traditional non-steroidal anti-inflammatories, daily dosing is not required, and some of the risks of long-term NSAID use can be avoided.

Other treatment options include glucosamine, chondroitin, green lipped muscle, and the injection of stem cells or platelet-rich plasma into stifle joints affected by CCLD. Unfortunately, studies have not had consistent follow-up in the majority of treated patients to fully evaluate the effectiveness of these treatments.

Pain management with anti-inflammatories and/or pain medications:

Patients with CCLD typically experience pain and gingerly use the affected limb. Pain management is a crucial aspect of treatment in the early stages of medical management and will likely be required intermittently throughout their life. Multiple medications may be prescribed to keep your pet comfortable.

Medicine

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs block pathways that lead to inflammation and pain and thus play a major role in the treatment of osteoarthritis and pain in dogs. It is very important that these medications be used judiciously, and only as prescribed by your veterinarian, as certain potential side effects and medical conditions may prohibit their use. Side effects may include vomiting, diarrhea, blood in the stool, not eating or drinking, lethargy, inactivity, or nausea.

Pils

Opioids:

A fentanyl transdermal patch is a type of opioid medication used to manage moderate to severe pain. It’s a strong opioid pain reliever that works by delivering fentanyl—a powerful synthetic opioid—through the skin and into the bloodstream at a steady dose over a three-day period. The patch is applied to a flat, non-irritated area on the skin, and changed every 72 hours as needed for continued pain management. Common side effects include drowsiness, nausea, vomiting, constipation, and skin reactions at the patch site. Serious side effects can include slow or shallow breathing, confusion, and severe drowsiness. It’s important to use these patches exactly as prescribed by a healthcare provider to avoid risks of misuse, addiction, and overdose. If you observe any side effects, please contact your veterinarian for advice.

Pils (1)

Gabapentin:

Veterinarians may recommend pet owners give recovering dogs Gabapentin right before meals. The drug works by blocking pain pathways in the nervous system to reduce discomfort. It’s important to note that while gabapentin is generally safe for dogs, it should always be administered under the guidance of a veterinarian to ensure proper dosage and to monitor for any potential side effects

Surgical Management

Surgical management of a cruciate deficiency stifle can be separated into three categories:

  1. Intracapsular repairs involve placement of a synthetic material in the same location of the cruciate ligament, and while these surgeries can provide great stability and outcomes they are frequently impacted by early failures.
  2. Extracapsular stabilisation surgeries involve placement of a synthetic material outside of the joint. This material provides temporary stability to the joint while the joint capsule itself thickens and strengthens until it can withstand the forces applied through it.
  3. Osteotomy stabilisation surgeries are often the preferred way to surgical manage cranial cruciate disease. These surgeries involve changing the anatomy of the knee joint by an osteotomy (a planned surgical cut through a bone) to reduce the biomechanical forces that the CCL was originally responsible for. Essentially these surgeries aim to eliminate the need for the CCL to be present for joint comfort and stability.

Extra-capsular lateral suture techniques

Extracapsular lateral sutures for the stabilisation of a cruciate deficient stifle is an older style of surgery.

Previously referred to as a DeAngelis procedure, these surgeries focus on using a synthetic materials, anchored at specific anatomical landmarks to temporarily replicate the stability provided by the cranial cruciate ligament.

While these synthetic materials are inpalce fibrous (scar) tissue develops, matures and solidifies around the joint providing onging stability.

Unfortunately, all extracapsular surgeries rely on the dog’s ability to develop sufficient fibrous tissue before the implant naturally fails due to mechanical stress and fatigue.

As a result, while these procedures can produce fantastic results equivalent to any other technique, the long term success rates for these procedure range from 70-85% (accounting for times when early implant failure occurs with insufficient fibrous tissue, or when the overall quality of the fibrous tissue created was never to be strong enough to prevent instability during ambulation and normal activities).

Osteotomy Techniques

Involve changing the anatomy of the knee joint by an osteotomy (cutting of the bone) to reduce the biomechanical force (tibial thrust) that the CCL was originally responsible for. There are many osteotomy procedures performed in veterinary medicine, but the overwhelming theme with all of them is to achieve a reduction of the tibial plateau angle (TPA) in order to generate stability in CCLD stifles.

The average TPA in a dog is approximately 30° and in patients with CCLD, the femur (thigh bone) slides down this tibial plateau slope during weight bearing. The goal with most osteotomy techniques is to reduce this angle to approximately 5°. By changing the TPA, the forces acting on the joint are neutralized during weight bearing, and thus the femur no longer slides down the slope of the top of the tibia. These osteotomy procedures aim to eliminate the need for a CCL to be present to resist tibial thrust and thereby create stability and comfort.

Osteotomy techniques include the tibial plateau leveling osteotomy (TPLO), CORA based leveling osteotomy (CBLO), triple tibial osteotomy (TTO) and the tibial wedge osteotomy (TWO). Other osteotomy technique, the tibial tuberosity advancement (TTA) and the modified Marquet procedure (MMP) rely on changing angle formed between the tibial plateau and the patellar ligament to create stability. While these two procedures are can be ideal for select cases, they are associated with higher frequencies of post operative meniscal trauma and prone to inaccuracies during pre-surgical planning which can result in persist tibial thrust after the surgery.

Ask Us Anything! Your Pet’s Health Comes First.

Contact us today for transparent, expert guidance on surgical care.